Tarsus Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87650L1035

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey S Farrow. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey S Farrow har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TARS / Tarsus Pharmaceuticals, Inc. See Remarks 36.704
US:GBT / Global Blood Therapeutics Inc. Chief Financial Officer 0
US:ZSPH / ZS Pharma, Inc. Chief Financial Officer 0
US:HPTX / Hyperion Therapeutics Inc CFO 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey S Farrow. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb TARS / Tarsus Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TARS / Tarsus Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insidersalg TARS / Tarsus Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TARS / Tarsus Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-06-17 TARS Farrow Jeffrey S 13.608 40,4200 13.608 40,4200 550.035 44 38.8200 -21.772 -3,96
2025-03-20 TARS Farrow Jeffrey S 1.186 50,1100 1.186 50,1100 59.430
2025-03-19 TARS Farrow Jeffrey S 1.254 47,4000 1.254 47,4000 59.440
2025-03-18 TARS Farrow Jeffrey S 1.284 46,2900 1.284 46,2900 59.436
2024-06-18 TARS Farrow Jeffrey S 10.445 27,4700 10.445 27,4700 286.924

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TARS / Tarsus Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey S Farrow som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-18 2025-06-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -13.608 36.704 -27,05 40,42 -550.035 1.483.576
2025-06-18 2025-06-16 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 27.881 50.312 124,30
2025-03-20 2025-03-20 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -1.186 22.431 -5,02 50,11 -59.430 1.124.017
2025-03-20 2025-03-19 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -1.254 23.617 -5,04 47,40 -59.440 1.119.446
2025-03-20 2025-03-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -1.284 24.871 -4,91 46,29 -59.436 1.151.279
2025-03-18 2025-03-15 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 8.019 26.155 44,22
2024-06-20 2024-06-18 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
S - Sale -10.445 18.136 -36,55 27,47 -286.924 498.196
2024-06-20 2024-06-17 4 TARS Tarsus Pharmaceuticals, Inc.
Common Stock
M - Exercise 27.881 28.581 3.983,00
2023-04-28 3/A TARS Tarsus Pharmaceuticals, Inc.
Common Stock
700
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -26.739 0 -100,00
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 23.653 26.739 766,46 16,40 387.909 438.520
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale -31.441 3.086 -91,06 68,00 -2.137.988 209.848
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.885 34.527 -5,18 68,15 -128.463 2.353.015
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.208 36.412 6,46
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 34.204 8,79
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.126 31.441 -6,33 32,40 -68.882 1.018.688
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.145 33.567 22,41
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28.628 28.628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.763 16.577 -14,29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.315 27.422 -4,58 29,87 -39.279 819.095
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 28.737 10,64
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 12.080 -20,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 6.250 -33,33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 0 -100,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.506 25.974 -14,78 29,33 -132.161 761.817
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 30.480 42,03
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.354 20.068 -17,83 27,33 -118.995 548.458
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 24.422 58,56
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.762 19.340 -12,50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.370 21.460 -6,00 29,85 -40.894 640.581
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.762 22.830 13,76
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.354 20.068 -17,83 27,33 -118.995 548.458
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 24.422 58,56
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22.102 22.102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.739 38.739
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 18.120 -14,29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 12.500 -20,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 5.750 -33,33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.063 0 -100,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -5.865 15.402 -27,58 49,49 -290.259 762.245
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12.083 21.267 131,57
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 21.140 -12,50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 15.625 -16,67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 8.625 -25,00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.062 3.063 -49,99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -5.946 9.184 -39,30 67,48 -401.236 619.736
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12.082 15.130 396,39
2020-07-15 2020-07-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -15.208 3.048 -83,30 75,00 -1.140.600 228.600
2020-06-11 2020-06-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -15.208 18.256 -45,45 67,00 -1.018.936 1.223.152
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42.400 42.400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.500 38.500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24.160 24.160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 18.750 -14,29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 11.500 -20,00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.063 6.125 -33,34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.398 33.464 -11,62 65,26 -287.013 2.183.861
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.063 37.862 31,47
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5.000 0 -100,00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.479 28.799 -7,93 76,88 -190.586 2.214.067
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5.000 31.278 19,03
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 21.875 -12,50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 14.375 -16,67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.062 9.188 -25,00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.421 26.278 -11,52 54,25 -185.589 1.425.582
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.062 29.699 43,91
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 5.000 -28,57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 20.637 -3,24 58,51 -40.489 1.207.471
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 21.329 10,35
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 17.250 -14,29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.063 12.250 -20,00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25.000 25.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40.000 40.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.164 19.329 -10,07 48,44 -104.824 936.297
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5.938 21.493 38,17
2018-11-28 2018-11-27 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -3.048 33.952 -8,24
2018-11-28 2018-11-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3.048 15.555 24,37 16,40 49.987 255.102
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 20.125 -12,50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.062 15.313 -16,66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.400 12.507 -16,10 43,15 -103.560 539.677
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5.937 14.907 66,19
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 7.000 -22,22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 8.970 -7,16 62,30 -43.112 558.831
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 9.662 26,10
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23.000 23.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.063 18.375 -14,29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.060 7.662 -12,15 59,60 -63.176 456.655
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3.063 8.722 54,13
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 9.000 -18,18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 5.659 -10,90 57,90 -40.067 327.656
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 6.351 45,97
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 11.000 -15,38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -683 4.351 -13,57 58,15 -39.716 253.011
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 5.034 65,92
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 13.000 -13,33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 3.034 -22,42 52,10 -45.692 158.071
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 3.911 104,66
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15.000 15.000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.062 21.438 -12,50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.151 1.911 -37,59 25,10 -28.890 47.966
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3.062 3.062
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 37.000 37.000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24.500 24.500
2015-12-21 2015-12-17 4 ZSPH ZS Pharma, Inc.
Employee Stock Option (NQ)
D - Sale to Issuer -77.900 0 -100,00
2015-12-21 2015-12-17 4 ZSPH ZS Pharma, Inc.
Employee Stock Option (ISO)
D - Sale to Issuer -7.100 0 -100,00
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -32.500 0 -100,00 46,00 -1.495.000
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -38.000 0 -100,00 46,00 -1.748.000
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -39.500 0 -100,00 46,00 -1.817.000
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -14.371 0 -100,00 46,00 -661.066
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (Right to Buy)
D - Sale to Issuer -23.346 0 -100,00 46,00 -1.073.916
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
D - Sale to Issuer -120.777 0 -100,00 46,00 -5.555.742
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
D - Sale to Issuer -22.687 0 -100,00 46,00 -1.043.602
2015-05-08 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
U - Other -878 0 -100,00 46,00 -40.388
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -629 14.371 -4,19
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -17.704 23.346 -43,13
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -53.184 0 -100,00
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -24.630 0 -100,00
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -24.630 0 -100,00
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
M - Exercise 629 144.402 0,44 10,95 6.888 1.581.202
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
M - Exercise 17.704 143.773 14,04 7,31 129.416 1.050.981
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
M - Exercise 53.184 126.069 72,97 4,08 216.991 514.362
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
M - Exercise 24.630 72.885 51,04 1,28 31.526 93.293
2015-05-05 2015-05-01 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
M - Exercise 24.630 72.885 51,04 1,28 31.526 93.293
2015-02-10 2015-02-09 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 32.500 32.500
2015-02-10 2015-02-09 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
A - Award 18.000 23.625 320,00
2015-01-05 2015-01-02 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
F - Taxes -685 5.625 -10,86 24,28 -16.632 136.575
2014-03-13 2014-03-11 4 HPTX HYPERION THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 38.000 38.000
2014-03-13 2014-03-11 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
A - Award 6.250 6.250
2013-05-01 2013-04-15 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (right to buy)
A - Award 39.500 39.500
2012-10-18 2012-10-16 4 HPTX HYPERION THERAPEUTICS INC
Stock Option (right to buy)
A - Award 15.000 15.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)